Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 44 min ago
Peer-reviewedCC BYFood Research International

Milk-derived casein glycomacropeptide improves colonic mucus function under Western-style diet feeding in a sialylation-dependent manner

Abstract

The colonic mucus layer is the primary interface between the host and the gut microbiota. It serves both as an ecological niche for bacteria and a barrier protecting the host from microbial exposure. Disruption of the mucus layer, particularly under Western-style diet (WSD) feeding, increases the risk of infection and inflammation. Here, we identify casein glycomacropeptide (CGMP), a milk-derived glycopeptide, as a novel dietary supplement capable of preserving mucus function under WSD consumption. Notably, we demonstrate that the sialylation level of CGMP is a key determinant of its protective effects. Supplementation of highly sialylated CGMP not only prevented WSD-induced mucus defects but also altered the gut microbiota composition, enhancing beneficial bacterial genera, particularly Bifidobacterium. Mechanistically, bacterial shifts were associated with increased production of the short-chain fatty acid propionate, which can induce mucus growth. Our findings thus reveal sialylated CGMP as a promising prebiotic supplement to counteract diet-induced mucus dysfunction, highlighting the importance of protein-bound glycan structures in modulating host-microbiota interaction.

Related

  1. Nfia-mediated troponin C activation enhances pluripotent stem cell-derived cardiomyocyte function and improves cardiac remodeling after myocardial infarction
    Chan Wang, Jiarui Shen, Hui Shen +1
    Cardiovascular Diagnosis and TherapyPeer-reviewedCC BY-NC-ND 4.0Full textMolecular biology & gene regulationPMC
  2. Magnetic Fields Improves the Cellular function in Hyperglycaemia
    B. Mukherjee, S. Chandra, A. Salam +2
    bioRxivPreprintAll rights reservedFull textMolecular biology & gene regulationbioRxiv
  3. GlycoStamp-seq: Single-cell nascent sialoglycometabolomics captures sialylation dynamics in immune cells of an oxaliplatin-treated bladder cancer mouse model
    Xiangyu Wu, Zihan Zhao, Shian Ouyang +12
    Nature CommunicationsPeer-reviewedCC BY-NC-ND 4.0Full textMolecular biology & gene regulationCrossref
  4. Rapsyn overexpression improves neuromuscular junction and skeletal muscle function after tourniquet-induced mouse hindlimb ischemia-reperfusion injuries
    Huiyin Tu, Emmanuel Adu-Agyekum, Aaron N. Barksdale +2
    Frontiers in bioengineering and biotechnologyPeer-reviewedCC BYFull textMolecular biology & gene regulationEurope PMCEurope PMCPMC
  5. The gut microbiota-derived butyrate improves gestational glucose homeostasis through HDAC3 inhibition and epigenetic activation of the SCGN/GLP-1 axis.
    Weiling Han, Yujie Zhang, Junhua Huang +8
    Journal of translational medicinePeer-reviewedCC BY-NC-NDFull textMolecular biology & gene regulationEurope PMCPMC
BibTeX
@article{wongkuna2026milkderived,
  title = {{Milk-derived casein glycomacropeptide improves colonic mucus function under Western-style diet feeding in a sialylation-dependent manner}},
  author = {Supapit Wongkuna and Vishnu Prasoodanan P.K. and Sandra Holmberg and Ann Bjørnshave and Bjoern Schroeder},
  journal = {Food Research International},
  year = {2026},
  month = sep,
  doi = {10.1016/j.foodres.2025.117206},
  url = {https://hal.science/hal-05772042v1},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Milk-derived casein glycomacropeptide improves colonic mucus function under Western-style diet feeding in a sialylation-dependent manner
AU  - Supapit Wongkuna
AU  - Vishnu Prasoodanan P.K.
AU  - Sandra Holmberg
AU  - Ann Bjørnshave
AU  - Bjoern Schroeder
PY  - 2026
DA  - 2026/09/30
JO  - Food Research International
DO  - 10.1016/j.foodres.2025.117206
UR  - https://hal.science/hal-05772042v1
AB  - The colonic mucus layer is the primary interface between the host and the gut microbiota. It serves both as an ecological niche for bacteria and a barrier protecting the host from microbial exposure. Disruption of the mucus layer, particularly under Western-style diet (WSD) feeding, increases the risk of infection and inflammation. Here, we identify casein glycomacropeptide (CGMP), a milk-derived glycopeptide, as a novel dietary supplement capable of preserving mucus function under WSD consumption. Notably, we demonstrate that the sialylation level of CGMP is a key determinant of its protective effects. Supplementation of highly sialylated CGMP not only prevented WSD-induced mucus defects but also altered the gut microbiota composition, enhancing beneficial bacterial genera, particularly Bifidobacterium. Mechanistically, bacterial shifts were associated with increased production of the short-chain fatty acid propionate, which can induce mucus growth. Our findings thus reveal sialylated CGMP as a promising prebiotic supplement to counteract diet-induced mucus dysfunction, highlighting the importance of protein-bound glycan structures in modulating host-microbiota interaction.
SN  - 0963-9969
ER  -